Acute Hepatitis and Acute Liver disease
Related Subjects:
|Hepatitis A
|Hepatitis B
|Hepatitis D
|Hepatitis E
|Chronic liver disease
|Cirrhosis
|Alkaline phosphatase (ALP)
|Liver Function Tests
|Ascites Assessment and Management
|Budd-Chiari syndrome
|Autoimmune Hepatitis
|Primary Biliary Cirrhosis
|Primary Sclerosing Cholangitis
|Wilson disease
|Hereditary Haemochromatosis
|Alpha-1 Antitrypsin (AAT) deficiency
|Non alcoholic steatohepatitis (NASH)
|Spontaneous Bacterial Peritonitis
|Alcoholism and Alcoholic Liver Disease
|Liver Transplantation
๐ก Always consider acute hepatitis causes as infection ๐ฆ , drugs ๐, and alcohol ๐บ.
Some are self-limiting; others progress to fulminant liver failure ๐จ or evolve into chronic hepatitis ๐ฐ๏ธ.
โน๏ธ Overview
- Hepatitis = hepatocyte necrosis + inflammation; can be reversible or progress to chronic liver disease.
- Fulminant liver failure = rapid onset with coagulopathy & encephalopathy; high mortality if untreated.
- NICE/UK guidance: early recognition, supportive care, toxin/drug withdrawal, ICU referral, and transplant evaluation if criteria met.
๐งฌ Causes of Acute Hepatitis
| Category |
Common Causes (UK / NICE) |
Key Points / Management |
| ๐ฆ Viral |
HAV, HBV, HCV, HDV, HEV; EBV, CMV, HSV |
Supportive for HAV/HEV; antivirals in selected HBV/HCV cases; avoid hepatotoxins |
| ๐ Drug/Toxin |
Paracetamol (commonest in UK), antibiotics, statins, anti-TB drugs, Amanita mushroom ๐ |
Stop culprit drug; NAC for paracetamol; supportive care; ICU if fulminant |
| ๐บ Alcoholic |
Alcohol binge โ alcoholic hepatitis |
Abstinence, supportive care; corticosteroids if severe (NICE NG148) |
| ๐ก๏ธ Autoimmune |
AIH โ ANA, SMA, LKM1 positive |
Steroids ยฑ azathioprine; rule out infection first |
| ๐งฌ Metabolic / Other |
Wilsonโs disease, haemochromatosis, ischaemic hepatitis, pregnancy-related (HELLP, AFLP) |
Specific therapy: chelation (Wilson), deliver fetus if pregnancy-related; perfusion support for ischaemia |
| โ Idiopathic |
Unknown etiology (~10โ20%) |
Supportive, monitor synthetic function, consider transplant if ALF |
๐ฉบ Clinical Features
- Non-specific: malaise, fatigue, nausea/vomiting ๐คข
- Classic: jaundice ๐ก, dark urine ๐งช, pale stools โช, RUQ pain
- Clues: cigarette distaste ๐ฌ (acute HBV), tender hepatomegaly
- Severe: hepatic encephalopathy ๐ง โ confusion โ coma; coagulopathy ๐ฉธ; may indicate fulminant liver failure ๐จ
๐ฌ Investigations (UK/NICE Approach)
| Test |
Purpose / Findings |
Clinical Tip |
| LFTs |
ALT/AST often >1000 โ paracetamol, viral, ischaemic; โ bilirubin; INR/PT prolonged |
High AST/ALT โ liver failure; check synthetic function (INR/albumin) |
| Viral Serology |
HAV IgM, HBsAg, anti-HCV, HEV IgM, HDV markers |
Essential for UK-relevant viral hepatitis screening |
| Autoantibodies |
ANA, SMA, LKM1 if autoimmune suspected |
Young female with high IgG โ consider AIH |
| Toxicology |
Paracetamol level, alcohol/drug screen |
Critical for identifying treatable drug-induced hepatitis |
| Imaging |
Ultrasound ยฑ Doppler to exclude obstruction or vascular causes |
Rapid bedside assessment for vascular or biliary pathology |
| Liver Biopsy |
Rarely acute; mainly chronic or unclear etiology |
Coagulopathy correction required if biopsy considered |
๐ Management (NICE/UK Guidelines)
- Supportive care: hydration, nutrition, monitor electrolytes, avoid hepatotoxins
- Drug-induced: stop offending drug; NAC for paracetamol overdose
- Alcoholic hepatitis: abstinence + supportive; corticosteroids if severe (NICE NG148)
- Viral hepatitis: supportive; antivirals for HBV/HCV in select cases; monitor for fulminant course
- Autoimmune hepatitis: steroids ยฑ azathioprine after excluding infection
- Ischaemic hepatitis: restore perfusion; treat underlying cardiac cause
- Pregnancy-related: prompt delivery if HELLP/AFLP
- Fulminant liver failure ๐จ: ICU support, manage complications (coagulopathy, encephalopathy, hypoglycaemia), early transplant referral ๐ฅ
๐ Prognosis
- HAV & HEV โ usually self-limiting ๐
- HBV & HCV โ risk of chronic hepatitis โ cirrhosis + HCC ๐
- Fulminant liver failure โ high mortality; transplant may be lifesaving
๐ฏ Exam Pearls
- Paracetamol overdose = commonest cause of ALF in UK โ NAC early saves lives
- HEV = severe in pregnancy โ high maternal/fetal mortality ๐คฐ
- Autoimmune hepatitis = young woman + โ IgG + ANA/SMA positive
- Cigarette distaste ๐ฌ โ acute HBV
- Prognostic markers: โ INR, bilirubin, encephalopathy grade
Additional related clinical topics
Acute Liver Disease & Acute Liver Failure โ
โ ๏ธ Acute liver disease is not the same as acute liver failure.
Acute liver disease may range from mild hepatocellular injury to life-threatening acute liver failure (ALF).
ALF is defined by acute liver injury with impaired synthetic function, usually INR โฅ1.5, plus hepatic encephalopathy, in a patient without known pre-existing cirrhosis.
๐ฉบ Acute Liver Disease & Acute Liver Failure
- Acute liver injury: sudden hepatocellular injury with raised ALT/AST, but without encephalopathy.
- Acute severe hepatitis: severe liver injury with jaundice and coagulopathy, but no encephalopathy yet.
- Acute liver failure: acute liver injury with coagulopathy and hepatic encephalopathy.
- Acute-on-chronic liver failure: acute deterioration in a patient with known or previously unrecognised chronic liver disease.
- ๐จ ALF is a medical emergency because deterioration can be rapid, with cerebral oedema, hypoglycaemia, sepsis, renal failure and multiorgan failure.
๐ Classification of Acute Liver Failure
| Type |
Jaundice โ Encephalopathy |
Common Causes |
Key Features |
| Hyperacute |
<7 days |
๐ Paracetamol toxicity, HAV, HBV, HEV, ischaemic hepatitis |
Rapid deterioration, high cerebral oedema risk, but potentially better transplant-free survival if treated early. |
| Acute |
8โ28 days |
๐ฆ Viral hepatitis, drug-induced liver injury, autoimmune hepatitis |
Cerebral oedema possible; prognosis depends strongly on cause and severity. |
| Subacute |
5โ12 weeks |
๐ Drug-induced injury, autoimmune, viral, indeterminate, Wilson disease |
Less cerebral oedema than hyperacute ALF, but often worse spontaneous recovery. |
๐ง Causes of Acute Liver Disease & ALF
- ๐ Paracetamol toxicity: most important treatable cause in the UK; risk increased by delayed presentation, staggered overdose, alcohol misuse or malnutrition.
- ๐ Other drugs/toxins: antibiotics, antiepileptics, NSAIDs, statins, antituberculous therapy, herbal remedies, recreational drugs, Amanita phalloides mushrooms.
- ๐ฆ Viral hepatitis: HAV, HBV, HEV; also HSV, VZV, EBV, CMV and adenovirus, especially in pregnancy or immunosuppression.
- ๐ก Autoimmune hepatitis: may present acutely or as ALF.
- ๐งฌ Metabolic: Wilson disease, acute fatty liver of pregnancy, Reye syndrome.
- ๐คฐ Pregnancy-related: HELLP syndrome, acute fatty liver of pregnancy, severe pre-eclampsia.
- ๐ฉธ Vascular/ischaemic: shock liver, BuddโChiari syndrome, heatstroke, severe cardiac failure.
- ๐ท Alcoholic hepatitis: causes acute severe liver disease but often occurs on a background of chronic liver injury, so distinguish from true ALF.
- โ Indeterminate: no cause found despite investigation.
๐ฉบ Clinical Features
- ๐คข Nausea, vomiting, anorexia, malaise and abdominal pain.
- ๐ก Jaundice, dark urine, pale stools and pruritus.
- ๐ง Encephalopathy: sleep disturbance, confusion, agitation, asterixis, reduced consciousness or coma.
- ๐ฉธ Bleeding or bruising from coagulopathy.
- ๐ฌ Hypoglycaemia, especially in severe hepatocellular failure.
- ๐ซ Right upper quadrant pain or tender hepatomegaly may occur.
- ๐ซ Stigmata of chronic liver disease are usually absent in true ALF.
๐ง Hepatic Encephalopathy Grades
| Grade |
Clinical Features |
| Grade 1 |
Sleep disturbance, poor concentration, mild confusion, irritability or altered behaviour. |
| Grade 2 |
Drowsiness, disorientation, asterixis, personality change. |
| Grade 3 |
Marked confusion, somnolence, incoherent speech, responds to pain/voice. |
| Grade 4 |
Coma, may be unresponsive to pain. |
๐ฉบ Acute Liver Failure vs Chronic Liver Disease
| Feature |
Acute Liver Failure โก |
Chronic Liver Disease ๐ฐ๏ธ |
| Onset โฑ๏ธ |
Rapid: days to weeks. |
Gradual: months to years. |
| Encephalopathy ๐ง |
Early and rapidly progressive. |
Usually later or precipitated by infection, GI bleed, constipation, sedatives or renal failure. |
| Coagulopathy ๐ฉธ |
INR rises early due to acute loss of synthetic function. |
May be chronically abnormal; synthetic failure often evolves over time. |
| Ascites ๐ง |
Usually absent at first, may develop later. |
Common with portal hypertension. |
| Splenomegaly ๐ณ |
Usually absent. |
Common due to portal hypertension. |
| Spider naevi / palmar erythema ๐ท๏ธ |
Usually absent. |
Common stigmata of chronic liver disease. |
| Muscle wasting ๐ช |
Usually absent initially. |
Common in advanced chronic liver disease. |
๐ก Clinical tip: AST/ALT tell you about hepatocyte injury; INR, glucose, lactate, bilirubin trend and encephalopathy tell you about liver failure.
A patient can have ALT >1000 without liver failure, but confusion plus INR elevation is an emergency.
๐ Initial Investigations
| Investigation |
Why It Matters |
| LFTs: ALT, AST, ALP, GGT, bilirubin |
Pattern of injury: hepatocellular, cholestatic or mixed. |
| INR / PT |
Key marker of synthetic failure and prognosis. |
| Glucose |
Hypoglycaemia is common in severe ALF and can be fatal. |
| U&E, creatinine, phosphate, magnesium |
Renal failure and electrolyte abnormalities are common. |
| FBC, CRP, cultures |
Assess infection, sepsis, anaemia and platelet count. |
| ABG/VBG, lactate, pH |
Acidosis and lactate are important severity markers, especially in paracetamol toxicity. |
| Paracetamol level |
Check in all unexplained acute hepatitis or ALF, even if overdose is denied. |
| Toxicology screen |
Consider drugs, toxins, recreational substances and poisoning. |
| Viral screen |
HAV IgM, HBsAg, anti-HBc IgM, HBV DNA, HCV Ab/RNA, HEV IgM/RNA; consider HSV/VZV/EBV/CMV. |
| Autoimmune screen |
ANA, SMA, LKM antibodies, IgG. |
| Metabolic tests |
Caeruloplasmin, copper studies, ferritin, transferrin saturation, alpha-1 antitrypsin if indicated. |
| Pregnancy test |
Essential in women of childbearing potential; consider HELLP and acute fatty liver of pregnancy. |
| Ultrasound liver + Doppler |
Assess biliary obstruction, hepatic/portal vein thrombosis, BuddโChiari, tumour and chronic liver morphology. |
๐ Immediate Management
- ๐จ Escalate early: involve senior medical, ICU, hepatology and a liver transplant centre if ALF is suspected.
- ๐ ABCDE assessment: protect airway, give oxygen if needed, support circulation and monitor mental state.
- ๐ Admit to HDU/ICU if encephalopathy, rising INR, hypoglycaemia, acidosis, renal failure, severe vomiting, sepsis or rapid deterioration.
- ๐ฌ Prevent hypoglycaemia: frequent glucose checks and IV dextrose if needed.
- ๐ง Fluids and electrolytes: correct hypovolaemia, sodium, potassium, phosphate and magnesium carefully.
- ๐ฆ Infection: culture and treat suspected sepsis promptly; avoid unnecessary delays.
- ๐ง Encephalopathy: avoid sedatives where possible; manage airway risk; treat cerebral oedema urgently if suspected.
- ๐ฉธ Coagulopathy: do not correct INR routinely with FFP unless bleeding or before invasive procedures, because INR is a key prognostic marker.
- ๐งช Serial monitoring: INR, LFTs, glucose, lactate, pH, renal function, phosphate and conscious level.
- ๐ซ Avoid hepatotoxins: alcohol, unnecessary paracetamol, NSAIDs and sedatives.
๐ Cause-Specific Treatment
- ๐ Paracetamol toxicity: give IV N-acetylcysteine immediately if indicated; do not wait if high suspicion or delayed presentation.
- ๐ Non-paracetamol ALF: N-acetylcysteine may still be considered early under specialist guidance.
- ๐ฆ HSV/VZV hepatitis: IV aciclovir if suspected, especially in pregnancy or immunosuppression.
- ๐ฆ Severe acute HBV: discuss nucleos(t)ide analogue therapy such as tenofovir or entecavir with hepatology.
- ๐ก Autoimmune hepatitis: corticosteroids may be considered by specialists after infection and sepsis are assessed.
- ๐ Amanita mushroom poisoning: urgent toxicology/hepatology input; consider silibinin where available and transplant assessment.
- ๐คฐ Pregnancy-related disease: urgent obstetric, anaesthetic and hepatology input; delivery is definitive treatment for HELLP/acute fatty liver of pregnancy.
- ๐งฌ Wilson disease ALF: urgent transplant-centre discussion; prognosis without transplant is poor.
- ๐ฉธ BuddโChiari syndrome: anticoagulation and specialist consideration of thrombolysis, TIPS or transplant.
- ๐ซ Ischaemic hepatitis: treat shock, hypoxia or cardiac failure.
๐ Kingโs College Criteria - Transplant Assessment
๐ Kingโs College criteria help identify patients who may need urgent liver transplantation.
They do not replace clinical judgement: discuss early with a liver transplant centre if ALF is suspected, especially with encephalopathy, rising INR, acidosis, renal failure or lactate elevation.
| Cause |
Criteria Suggesting Poor Prognosis / Transplant Need |
| Paracetamol-related ALF |
Arterial pH <7.3 after fluid resuscitation
OR
All 3 of: INR >6.5, creatinine >300 micromol/L, and grade 3โ4 encephalopathy.
|
| Non-paracetamol ALF |
INR >6.5 regardless of encephalopathy grade
OR
Any 3 of: age <10 or >40 years, non-A/non-B hepatitis or drug-induced cause, jaundice-to-encephalopathy interval >7 days, INR >3.5, bilirubin >300 micromol/L.
|
๐ง Cerebral Oedema & Raised ICP
- More common in hyperacute ALF and grade 3โ4 encephalopathy.
- Warning signs: falling GCS, agitation, pupillary changes, hypertension/bradycardia, seizures or abnormal posturing.
- Manage in ICU with head-up positioning, avoidance of hypoxia/hypotension, controlled ventilation if intubated, and specialist osmotherapy such as hypertonic saline or mannitol.
- Avoid hyponatraemia and fever; maintain adequate cerebral perfusion.
โ ๏ธ Complications
- ๐ฌ Hypoglycaemia.
- ๐ฉธ Coagulopathy and bleeding.
- ๐ง Cerebral oedema and raised intracranial pressure.
- ๐ฆ Infection and sepsis.
- ๐ซ Acute kidney injury and hepatorenal physiology.
- ๐ซ Respiratory failure or aspiration.
- ๐งช Metabolic acidosis, lactate elevation and electrolyte abnormalities.
- ๐ซ Multiorgan failure.
๐ Exam Pearls
- โ ๏ธ Acute liver injury becomes acute liver failure when there is coagulopathy plus encephalopathy.
- ๐งช ALT >1000 suggests paracetamol toxicity, viral hepatitis or ischaemic hepatitis.
- ๐ฉธ INR is more important than ALT for assessing liver failure severity.
- ๐ฌ Always check glucose: hypoglycaemia can be life-threatening.
- ๐ Check a paracetamol level even if overdose is not disclosed.
- ๐ Early transplant-centre discussion saves lives; do not wait until the patient is moribund.
- ๐ง Lactulose is standard for chronic hepatic encephalopathy, but in ALF the priority is ICU-level cerebral oedema and airway management.
๐ง Teaching Note
Acute liver failure is dangerous because the liver suddenly loses its ability to perform synthetic, metabolic and detoxifying functions.
INR rises because clotting factors have short half-lives, glucose falls because hepatic glycogen and gluconeogenesis fail, and encephalopathy develops as toxins and inflammatory mediators affect the brain.
Marked ALT/AST means hepatocytes are injured, but it does not by itself prove liver failure.
The key bedside question is: is the patient coagulopathic, hypoglycaemic, acidotic or encephalopathic?
๐ References & UK Resources
Drug induced liver disease
โ ๏ธ Key Point: Drug-induced liver injury (DILI) ranges from mild enzyme derangement to fulminant hepatic failure.
Some drugs (e.g. paracetamol, methotrexate, Co-Amoxiclav) are classically examined causes.
Early recognition + withdrawal of the drug is lifesaving.
๐ Types of Liver Injury & Drug Associations
| Side Effect |
Associated Drugs |
Typical Onset |
| Cholestasis ๐ก |
Chlorpromazine, high-dose OCPs, AmoxicillinโClavulanate |
Within 1 month โ jaundice + pruritus |
| Mixed Hepatocellular/Cholestatic Injury โ๏ธ |
NSAIDs, Statins, Co-Amoxiclav, Co-trimoxazole |
Variable onset; can occur any time during therapy |
| Acute Hepatitis ๐งช |
Isoniazid, Rifampicin, Methyldopa, Halothane, Paracetamol (OD) |
Weeksโmonths; marked ALT/AST rise |
| Steatohepatitis (NASH-like) ๐ |
Amiodarone, Tamoxifen, Valproate, Tetracyclines |
Monthsโyears; hepatocyte fat accumulation |
| Venous Outflow Obstruction (VOD) ๐ฉธ |
Azathioprine, 6-MP, Busulfan, chemotherapy agents |
Weeksโmonths; hepatic congestion, fibrosis |
| Fibrosis / Cirrhosis ๐ชต |
Methotrexate (dose-dependent), Antiretrovirals, Methyldopa |
Years of cumulative use |
| Granulomatous Hepatitis ๐งฉ |
Allopurinol, Quinidine, Sulfonamides, Phenytoin |
Weeksโmonths; biopsy shows non-caseating granulomas |
๐ฉบ Assessment of Suspected DILI
- LFT Monitoring: ALT/AST (hepatocellular), ALP/GGT (cholestatic), bilirubin. Always compare to baseline.
- Imaging: USS or CT to exclude obstruction; MRCP if biliary cause suspected.
- Liver Biopsy: Confirms diagnosis + defines pattern (hepatitic, cholestatic, granulomatous).
- Risk Factors: Age, alcohol, pre-existing liver disease, polypharmacy, genetic susceptibility.
๐ก๏ธ Prevention & Monitoring Strategies
- Baseline LFTs: For high-risk drugs (e.g. methotrexate, isoniazid, statins).
- Patient Education: Warn about jaundice, dark urine, pale stools, RUQ pain.
- Medication Review: Check for drug interactions that increase hepatotoxicity.
- Alternative Therapy: Use safer agents if risk factors present.
๐ก Clinical Pearls
- Co-Amoxiclav โ exam-favourite cause of cholestatic jaundice.
- Paracetamol โ commonest cause of fulminant hepatic failure in UK (treat with NAC promptly).
- Methotrexate โ monitor LFTs & cumulative dose โ risk of fibrosis/cirrhosis.
- Halothane hepatitis โ rare but severe immune-mediated hepatitis after anaesthetic exposure.